Locations:
Search IconSearch
October 22, 2025/Neurosciences/Research

DBS Trial Expected to Yield Novel Insights into Exercise and Parkinson’s

Cleveland Clinic researchers awarded $3.2 million for first-of-its-kind investigation

Man on an exercise bike with another man assisting

New Cleveland Clinic research will gather data derived from deep brain stimulation (DBS) devices to study neural mechanisms underlying the benefits of aerobic exercise in people with advanced Parkinson’s disease (PD).

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

The study, led by Jay Alberts, PhD, Vice Chair of Innovation at Cleveland Clinic’s Neurological Institute and Staff, Biomedical Engineering, has been awarded a five-year, $3.2 million grant from the National Institutes of Health. It expands upon the Alberts lab's seminal tandem cycling study, which established the positive effects of aerobic exercise on motor, memory and cognitive processing symptoms in those with PD.

“This will be the first study I'm aware of to look at a relatively long-term exercise intervention for patients with deep brain stimulation,” says Dr. Alberts. “It has the potential to transform our understanding of Parkinson's disease as well as our general understanding of the impact of exercise on brain function. That knowledge could be extended to individuals who do not have Parkinson's disease. And anything we can do to better understand that, to help facilitate and potentially motivate individuals from an exercise perspective, would be impactful.”

Broadly, the study focus will be on two areas of inquiry:

  • Do the benefits of aerobic exercise (enhanced motor, cognitive and dual-task performance) extend to people with advanced PD using DBS?
  • What is the neural mechanism(s) underlying these exercise induced improvements?

“Results will provide insight into what exercise is doing, from a neural perspective, to the area of the brain affected by Parkinson's disease,” says Dr. Alberts. “We know exercise helps symptoms, but now we'll actually be able to see and understand the mechanism underlying those improvements.

Advertisement

“Once we understand the mechanism, then we may be able to develop therapeutics to replicate the positive effects,” he adds. “So instead of searching for the elusive ‘exercise pill,’ we may be able to create exercise DBS parameters.”

Study design

Participants will be enrolled in an eight-week exercise cycling program. They will be randomized to either a voluntary (VE) program or a forced exercise (FE) program.

The VE group will exercise at a cadence of 60 rpms or fewer; the FE group will exercise on a motorized cycle that augments the participants’ self-selected pace to 80-90 rpms.

“We do not focus too much on heart rate with PD patients because they experience chronotropic incompetence, which can make it difficult for them to reach a target heart right,” Dr. Alberts explains. “Heart rate is affected by pain, dehydration, sleep and other factors, and PD patients may have any of those issues. We previously found that a more important predictor of a positive outcome with exercise is power, or the watts produced during the exercise, because it is a direct measure of work performed.”

Both groups will exercise three times a week for the eight weeks. Their DBS device will gather neural activity data from the subthalamic nucleus (STN) and EEG will record cerebral cortex data. Together these data will aid in identifying neural mechanisms associated with PD symptom improvements after long-term aerobic exercise.

Assessments will be made at baseline, end of treatment and four weeks after the end of treatment for motor, cognitive and dual-task function as well as underlying cortical and subcortical neural data.

Advertisement

Hypothesis

The cortico-basal ganglia-thalamic (CBGT) loop is a neural circuit key to controlling movement, motor learning, decision-making and short-term memory. Its dysregulation is associated with Parkinson's disease and other conditions. The researchers hypothesize that long-term aerobic exercise normalizes CBGT activity by reducing beta oscillations in the STN. Reduced STN beta oscillations lead to improvements in motor, cognitive and dual-task performance.

Analyzing STN and cerebral cortex data before and after long-term exercise is expected to yield unprecedented insight into neural mechanisms underlying the positive effects of exercise.

Key takeaways

In addition to the novel direction of the study, Dr. Alberts says it’s notable that existing “off-the-shelf” technology (Medtronic Percept DBS system) will be used to provide insight into exercise mechanisms. And because two modes of exercise will be studied (VE v. FE), the research should yield insights which mode is better or whether there is a superior mode for certain individuals.

Advertisement

Related Articles

Photo of Dr. Ford
March 2, 2026/Neurosciences/Podcast
Neuroethics Conversations: Guidelines for Care (Podcast)

Ethical guidance provides guardrails so medical advances benefit patients

red blood cells floating in a blood vessel
February 27, 2026/Neurosciences/Cerebrovascular
Factor XIa Inhibition Drives Down Recurrent Stroke Risk Without Rise in Bleeding

OCEANIC-STROKE results represent long-sought advance in secondary stroke prevention

two brightly colored brain scans side by side
February 25, 2026/Neurosciences/Epilepsy
MR Fingerprinting Shows Potential to Reshape FCD Detection and Epileptogenicity Mapping

Two studies from Cleveland Clinic may help advance the technology toward broader clinical use

MRI scan of the side of a human head
February 20, 2026/Neurosciences/Cerebrovascular
Susac Syndrome: Insights on Rare Endotheliopathy From Largest Single-Center Cohort to Date

Distinct MRI signature includes lesions beyond the corpus callosum, features predictive of vision and hearing loss

Symbolic photo illustration: stethoscope on a medical dictionary
Is ‘Atypical Parkinsonism’ a Useful Term?

An argument for clarifying the nomenclature

Dr. Jagan Pillai against a decorative background
February 16, 2026/Neurosciences/Podcast
Blood Tests For Alzheimer’s: Diagnostic Help Comes With New Questions Too (Podcast)

An expert talks through the benefits, limits and unresolved questions of an evolving technology

stylized human brain against DNA double helix background
February 13, 2026/Neurosciences/Brain Tumor
Neurologic Manifestations of PTEN Hamartoma Tumor Syndrome Get Their Due in First-Ever Guidelines

Recommendations on identifying and managing neurodevelopmental and related challenges

brain scan showing a large white-rimmed lesion in top left portion
February 11, 2026/Neurosciences/Brain Tumor
Novel Strategies to Enhance Chemotherapy in Advanced Glioblastoma

Phase 2 trials investigate sitagliptin and methimazole as adjuvant therapies

Ad